SCAC | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,036 results for “SCAC”

Trials

View all 1899 →

An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC)

First posted Apr 4, 2025

RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7

37 participants · First posted Dec 23, 2009

The KinematX Midcarpal Total Wrist Arthroplasty Registry

50 participants · First posted Feb 9, 2023

Drugs

View all 24 →

ZD55-Smac

SCAR-02

SCAL-266

News

View all 113 →

Retifanlimab Plus Chemotherapy Shows Promise in Advanced Squamous Cell Anal Carcinoma

Retifanlimab Plus Chemotherapy Extends Progression-Free Survival in Advanced Squamous Cell Anal Carcinoma

Incyte's Zynyz Shows Promise in Frontline Anal Cancer Treatment

Page 1 of 204